Sentences with phrase «outstanding stock value»

A small cap company has been defined as a company with an outstanding stock value of under $ 500 million.

Not exact matches

That amounts to about 1.2 % of all shares outstanding, which could be worth more than $ 300 million if the company is valued at $ 25 billion (its last reported private valuation) when it goes public — and a lot more than that over time if the stock goes up.

The stock closed at $ 44.90 on its first day of trading, giving Twitter a value of more than $ 31 billion based on its outstanding stock, options and restricted stock that'll be available after the IPO.

Common stock, $ 0.001 par value, 150,000 shares authorized; 85,194 and 82,554 shares issued and outstanding at March 30, 2018 and December 31, 2017, respectively

Echelon is now focusing its growth on «smart» commercial & municipal LED lighting (although its fab-less chip business has apparently now stabilized after a long decline), and if the lighting business accelerates (and it could, due to recent sales force hires and new products), I think there's a chance it can hit a break - even annualized revenue run - rate of $ 40 million by Q4 - 2019 (pushed back from my earlier hoped - for timeline) at which point — assuming $ 14 million of remaining net cash (vs. an estimated $ 18 million at the end of Q2 2018) and 4.7 million shares outstanding (vs 4.52 million today), an enterprise value of 1x revenue on this 53 % gross margin company would put the stock in the mid - $ 11s per share.

With virtually identical market capitalization (the price it would take to buy all shares of a company's outstanding common stock at the current market value), what exactly is an investor in each respective firm getting for his or her money?

With stock options, our executives can realize value only to the extent that the market price of our common stock increases during the period that the option is outstanding, which provides a strong incentive to our executives to increase stockholder value.

The following may be true of a potential takeover: • the company has fewer than 50 million shares outstanding; • management is dominated by persons near retirement age; • management's record on innovations and improving returns has been poor; • the company owns assets whose market values are potentially higher than those shown on the balance sheet; • outside investors have been steadily buying the stock.

In addition, each share of our Class B common stock will convert automatically into one share of our Class A common stock upon any transfer, whether or not for value, except for transfers to existing holders of Class B common stock and certain other transfers described in our amended and restated certificate of incorporation, or upon the affirmative vote of a majority of the voting power of the outstanding shares of our Class B common stock, voting separately as a class.

In August 2012, to create incentives for continued long - term success from the then - recently launched Model S program as well as from Tesla's then - planned Model X and Model 3 programs, and to further align executive compensation with increases in stockholder value, the Board granted to Mr. Musk a stock option award to purchase 5,274,901 shares of Tesla's common stock (the «2012 CEO Performance Award»), representing 5 % of Tesla's total issued and outstanding shares at the time of grant.

Common stock (2 billion shares authorized at $ 0.01 par value; 399.7 million shares and 398.3 million shares issued and outstanding at March 31, 2018 and December 31, 2017)

The term of an incentive stock option may not exceed ten years, except that with respect to any participant who owns more than 10 % of the voting power of all classes of our outstanding stock, the term must not exceed five years and the exercise price must equal at least 110 % of the fair market value on the grant date subject to the provisions of our 2015 Plan.

Apart from total debt, which includes the operating leases noted above, one of the largest adjustments to shareholder value was $ 231 million in outstanding employee stock options.

So, a value stock, basically, is a stock that represents «an outstanding company at a sensible price» according to Buffett.

Marriott Vacations Worldwide Corporation (NYSE: VAC)(«MVW» or the «Company») and ILG (Nasdaq: ILG) today announced that they have entered into a definitive agreement under which MVW will acquire all of the outstanding shares of ILG in a cash and stock transaction with an implied equity value of approximately $ 4.7 billion.

ORLANDO, Fla. and MIAMI — April 30, 2018 — Marriott Vacations Worldwide Corporation (NYSE: VAC)(«MVW» or the «Company») and ILG (Nasdaq: ILG) today announced that they have entered into a definitive agreement under which MVW will acquire all of the outstanding shares of ILG in a cash and stock transaction with an implied equity value of approximately $ 4.7 billion.

Liabilities such as debt, underfunded pensions, and outstanding employee stock options are deducted from the DCF value, as they are senior claims on cash flows that must be satisfied before existing shareholders can be paid.

The outstanding stock shares become deal stock when events affecting the value of a stock begin to transmit.

on a pro forma basis, giving effect to (i) the automatic conversion of all of our outstanding shares of convertible preferred stock other than Series FP preferred stock into shares of Class B common stock and the conversion of Series FP preferred stock into shares of Class C common stock in connection with our initial public offering, (ii) stock - based compensation expense of approximately $ 1.1 billion associated with outstanding RSUs subject to a performance condition for which the service - based vesting condition was satisfied as of December 31, 2016 and which we will recognize on the effectiveness of our registration statement in connection with a qualifying initial public offering, as further described in Note 1 to our consolidated financial statements included elsewhere in this prospectus, (iii) the increase in accrued expenses and other current liabilities and an equivalent decrease in additional paid - in capital of $ 187.2 million in connection with the withholding tax obligations, based on $ 16.33 per share, which is the fair value of our common stock as of December 31, 2016, as we intend to issue shares of Class A common stock and Class B common stock on a net basis to satisfy the associated withholding tax obligations, (iv) the net issuance of 7.6 million shares of Class A common stock and 5.5 million shares of Class B common stock that will vest and be issued from the settlement of such RSUs, (v) the issuance of the CEO award, as described below, and (vi) the filing and effectiveness of our amended and restated certificate of incorporation which will be in effect on the completion of this offering.

Earnings Per Share (EPS)-- The company's profit divided by the average number of outstanding shares, or shares currently in the market; gives you an idea of the stock's value

No participant will have the right to purchase shares of our Class A common stock in an amount, when aggregated with purchase rights under all our employee stock purchase plans that are also in effect in the same calendar year, that have a fair market value of more than $ 25,000, determined as of the first day of the applicable purchase period, for each calendar year in which that right is outstanding.

The pro forma consolidated balance sheet data gives effect to (i) the automatic conversion of all of our outstanding shares of convertible preferred stock other than Series FP preferred stock into shares of Class B common stock and the conversion of Series FP preferred stock into shares of Class C common stock in connection with our initial public offering, (ii) stock - based compensation expense of approximately $ 1.1 billion associated with outstanding RSUs subject to a performance condition for which the service - based vesting condition was satisfied as of December 31, 2016 and which we will recognize on the effectiveness of our registration statement in connection with this offering, as further described in Note 1 to our consolidated financial statements included elsewhere in this prospectus, (iii) the increase in accrued expenses and other current liabilities and an equivalent decrease in additional paid - in capital of $ 187.2 million in connection with the withholding tax obligations, based on $ 16.33 per share, which is the fair value of our common stock as of December 31, 2016, as we intend to issue shares of Class A common stock and Class B common stock on a net basis to satisfy the associated withholding tax obligations, (iv) the net issuance of 7.6 million shares of Class A common stock and 5.5 million shares of Class B common stock that will vest and be issued from the settlement of such RSUs, (v) the issuance of the CEO award, as described below, and (vi) the filing and effectiveness of our amended and restated certificate of incorporation which will be in effect on the completion of this offering.

The anticipated initial public offering price of our common stock is substantially higher than the net tangible book value per share of our outstanding common stock immediately after this offering.

JERUSALEM --(BUSINESS WIRE)-- Apr. 21, 2015 — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced a proposal to acquire all of the outstanding shares of Mylan N.V. (NASDAQ: MYL) in a transaction valued at $ 82.00 per Mylan share, with the consideration to be comprised of approximately 50 percent cash and 50 percent stock.

Style Categories: Large Cap, Mid Cap, Small Cap, Growth, Value, Grth / Val or Blend («Cap» denotes capitalization, which is market price per share times number of common stock shares outstanding).

Divide the company value by the number of shares of common stock outstanding to find the intrinsic value of a share of stock.

For nonstatutory stock options and incentive stock options granted to employees who do not own more than 10 % of the voting power of all classes of our outstanding stock, the exercise price must equal at least 100 % of the fair market value.

The term of an incentive stock option may not exceed 10 years, except that with respect to any participant who owns more than 10 % of the voting power of all classes of our outstanding stock, the term must not exceed 5 years and the exercise price must equal at least 110 % of the fair market value on the grant date.

The assumed initial public offering price of $ per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, is substantially higher than the net tangible book value per share of our outstanding common stock immediately after this offering.

terminate either (a) each outstanding option or (b) each outstanding option that is fully exercisable as of the date of such transaction, in exchange for a cash payment equal in amount to the excess, if any, of the fair market value, as determined by our board of directors, of a share of our common stock over the per - share exercise price of each such option, multiplied by the number of shares subject to each such option.

The purchase price per share in the tender offer represented an excess to the fair value of the Company's outstanding common stock and Series A through Series F convertible preferred stock, as determined by the Company's most recent valuation of its capital stock at time of the transaction.

When interest rates rise from 5 % to 10 %, investors value the profits earned one year from now by the JayZ company much less and are not willing to pay as much for the outstanding share of stock.

The term of an incentive stock option may not exceed ten years, except that with respect to any participant who owns more than 10 % of the voting power of all classes of our outstanding stock, the term must not exceed five years and the exercise price must equal at least 110 % of the fair market value on the grant date.

If a stock price is somehow chronically low in relation to the fundamentals of the underlying business, buying 100 % of the outstanding shares removes the veil, and closes the gap between price and value.

BOSTON (March 12, 2018)-- MFS Investment Grade Municipal Trust (the «fund»)(NYSE: CXH) announced today that it will conduct a cash tender offer to purchase up to 7.5 percent of the fund's outstanding common shares (the «shares») at a price per share equal to 98 percent of the fund's net asset value (NAV) per share as of the close of regular trading on the New York Stock Exchange (NYSE) on the date the tender offer expires.

Operating Leases)-- Value of Outstanding Stock Options — Minority Interests.

8:00 a.m. - 9:30 a.m. Bill Child Chairman, R.C. Willey Home Furnishings (a wholly owned subsidiary of Berkshire Hathaway) Topic: «How to Build a Business Warren Buffett Would Buy: The R.C. Willey Story» 9:40 a.m. - 10:40 a.m. Robert Hagstrom Author and Portfolio Mgr, Legg Mason Growth Trust Topic: «Go Big: The Investment Case for US Multinationals» 10:50 a.m. — 11:50 p.m. Chuck Akre Managing Member and CEO Akre Capital Topic: «Finding Outstanding Investments» 11:50 a.m. - 12:50 p.m. Networking Lunch - Executive Deli Sandwiches in the atrium Sponsored by Morningstar 12:50 p.m. - 1:50 p.m. Pat Dorsey Author, Director of Research - Sanibel Captiva Trust Topic: «10 Years, 100 Analysts and 2,000 Stocks: Learning From Experience» 2:00 p.m. - 3:00 p.m. Tom Russo Partner, Gardner Russo & Gardner Topic: «Global Value Equity Investing»

The largest adjustment to shareholder value came in the form of $ 105 million in outstanding employee stock option liabilities.

Correspondingly, a stock that sells well below intrinsic value should be repurchased whether or not stock has previously been issued (or may be because of outstanding options).

And we've learned something else — the value of that stock is dependent on what people think the company is worth, and the total amount of shares outstanding.

For those of you who don't know, «market value» is computed by taking a company's outstanding shares of stock and multiplying them by the current stock price.

Price / book (or P / B) ratio is calculated by dividing the market price of a company's outstanding stock by its book value (total assets of a company less liabilities) and then adjusting for the number of shares outstanding.

BVF Acquisition LLC (the «Purchaser»), a wholly owned subsidiary of Biotechnology Value Fund, L.P. («BVF»), announced today that it has commenced a cash tender offer to purchase any and all of the outstanding common stock of Avigen, Inc. (NasdaqGM: AVGN)(«Avigen») that BVF does not own at a price of $ 1.00 per share under the conditions described below.

Three activist investors, Biotechnology Value Fund (BVF), Millennium Technology Value Partners and Highland Capital Management, hold approximately 45 % of NTII's outstanding stock and have called for its liquidation.

Biotechnology Value Fund (BVF) announced today that it intends to make a tender offer for all of the outstanding stock of Avigen, Inc. (NASDAQ: AVGN) that it does not own.

Avigen, Inc. (Nasdaq: AVGN), a biopharmaceutical company, today confirmed that BVF Acquisition LLC, a wholly owned subsidiary of Biotechnology Value Fund, L.P. (collectively, «BVF»), had commenced an unsolicited tender offer to purchase all of the outstanding shares of Avigen's common stock that BVF does not already own for $ 1.00 per share in cash.

The board of Avigen Inc (NASDAQ: AVGN) has responded to Biotechnology Value Fund's (BVF) cash tender offer to purchase the outstanding common stock of AVGN, writing that the offer is «inadequate and not in the best interests of stockholders.»

We, the Biotechnology Value Fund («BVF»), are the owners of 8,819,600 shares, or approximately 30 % of Avigen's outstanding common stock.

Three large shareholders, BVF, Millennium Technology Value Partners and Highland Capital, hold 45 % of NTII's outstanding stock.

Biotechnology Value Fund, L.P. To Make Tender Offer For Any And All Outstanding Shares Of Avigen At $ 1.00 Per Share Tender Offer provides stockholders with a near - term cash alternative if BVF nominees are elected BVF reaffirms support for downside - protected merger with MediciNova NEW YORK, Jan. 15 / PRNewswire / — Biotechnology Value Fund, L.P. («BVF») announced today that it intends to make a cash tender offer to purchase any and all of the outstanding common stock of Avigen, Inc. (Nasdaq: AVGN — News; «Avigen») that BVF does not own at a price of $ 1.00 per share under the conditions descrOutstanding Shares Of Avigen At $ 1.00 Per Share Tender Offer provides stockholders with a near - term cash alternative if BVF nominees are elected BVF reaffirms support for downside - protected merger with MediciNova NEW YORK, Jan. 15 / PRNewswire / — Biotechnology Value Fund, L.P. («BVF») announced today that it intends to make a cash tender offer to purchase any and all of the outstanding common stock of Avigen, Inc. (Nasdaq: AVGN — News; «Avigen») that BVF does not own at a price of $ 1.00 per share under the conditions descroutstanding common stock of Avigen, Inc. (Nasdaq: AVGN — News; «Avigen») that BVF does not own at a price of $ 1.00 per share under the conditions described below.